Loading…
Urine beyond electrolytes: diagnosis through extracellular vesicles
Extracellular vesicles (EV) reflect the pathophysiological state of their cells of origin and are a reservoir of renal information accessible in urine. When biopsy is not an option, EV present themselves as sentinels of function and damage, providing a non-invasive approach. However, the analysis of...
Saved in:
Published in: | Nefrología 2024-07, Vol.44 (4), p.503-508 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c2020-979fb4c610db2f3eef64e68812657bff0f2fc66447a0443b338c1771f03ca2a13 |
container_end_page | 508 |
container_issue | 4 |
container_start_page | 503 |
container_title | Nefrología |
container_volume | 44 |
creator | Anfaiha-Sanchez, Miriam Lago-Baameiro, Nerea Santiago-Hernandez, Aranzazu Martin-Blazquez, Ariadna Pardo, María Marta, Martin-Lorenzo Alvarez-Llamas, Gloria |
description | Extracellular vesicles (EV) reflect the pathophysiological state of their cells of origin and are a reservoir of renal information accessible in urine. When biopsy is not an option, EV present themselves as sentinels of function and damage, providing a non-invasive approach. However, the analysis of EV in urine requires prior isolation, which slows down and hinders transition into clinical practice. The aim of this study is to show the applicability of the “single particle interferometric reflectance imaging sensor” (SP-IRIS) technology through the ExoView® platform for the direct analysis of urine EV and proteins involved in renal function.
The ExoView® technology enables the quantification and phenotyping of EV present in urine and the quantification of their membrane and internal proteins. We have applied this technology to the quantification of urinary EV and their proteins with renal tubular expression, amnionless (AMN) and secreted frizzled-related protein 1 (SFRP1), using only 5 μl of urine. Tubular expression was confirmed by immunohistochemistry.
The mean size of the EV analysed was 59 ± 16 nm for those captured by tetraspanin CD63, 61 ± 16 nm for those captured by tetraspanin CD81, and 59 ± 10 for tetraspanin CD9, with CD63 being the majority EV subpopulation in urine (48.92%). The distribution of AMN and SFRP1 in the three capture tetraspanins turned out to be similar for both proteins, being expressed mainly in CD63 (48.23% for AMN and 52.1% for SFRP1).
This work demonstrates the applicability and advantages of the ExoView® technique for the direct analysis of urine EV and their protein content in relation to the renal tubule. The use of minimum volumes, 5 μl, and the total analysis time not exceeding three hours facilitate the transition of EV into daily clinical practice as sources of diagnostic information.
Las vesículas extracelulares (VEs) reflejan el estado fisiopatológico de sus células de origen y constituyen un reservorio de información renal accesible en orina. Cuando la biopsia no es una opción, las VEs se presentan como un centinela de funcionalidad y daño, constituyendo una aproximación no invasiva. Sin embargo, el análisis de las VEs de la orina requiere de un aislamiento previo que ralentiza y dificulta su traslación a la práctica clínica. El objetivo de este trabajo es mostrar la aplicabilidad de la tecnología “sensor de imágenes de reflectancia interferométrica de una sola partícula” (SP-IRIS) mediante la plataforma ExoView® pa |
doi_str_mv | 10.1016/j.nefroe.2023.05.020 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3084774706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2013251424001470</els_id><sourcerecordid>3084774706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2020-979fb4c610db2f3eef64e68812657bff0f2fc66447a0443b338c1771f03ca2a13</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0E4lH4BwjlyKVh_YjdcEBCFS-pEhd6thxnXVylcbETRP89qVoQJ067h5md2Y-QSwo5BSpvlnmLLgbMGTCeQ5EDgwNyyoDyMSuoOPyzn5CzlJYAsmClOiYnvIRCMF6ekuk8-hazCjehrTNs0HYxNJsO021We7NoQ_Ip695j6BfvGX510Vhsmr4xMfvE5G2D6ZwcOdMkvNjPEZk_PrxNn8ez16eX6f1sbIeKMC5V6SphJYW6Yo4jOilQTiaUyUJVzoFjzkophDIgBK84n1iqFHXArWGG8hG53t1dx_DRY-r0yqdtG9Ni6JPmMBFKCQVykIqd1MaQUkSn19GvTNxoCnqLTy_1Dp_e4tNQ6KHiYLvaJ_TVCutf0w-vQXC3E-Dw56fHqJP12FqsfRzQ6Tr4_xO-ARPkgsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3084774706</pqid></control><display><type>article</type><title>Urine beyond electrolytes: diagnosis through extracellular vesicles</title><source>ScienceDirect</source><creator>Anfaiha-Sanchez, Miriam ; Lago-Baameiro, Nerea ; Santiago-Hernandez, Aranzazu ; Martin-Blazquez, Ariadna ; Pardo, María ; Marta, Martin-Lorenzo ; Alvarez-Llamas, Gloria</creator><creatorcontrib>Anfaiha-Sanchez, Miriam ; Lago-Baameiro, Nerea ; Santiago-Hernandez, Aranzazu ; Martin-Blazquez, Ariadna ; Pardo, María ; Marta, Martin-Lorenzo ; Alvarez-Llamas, Gloria</creatorcontrib><description>Extracellular vesicles (EV) reflect the pathophysiological state of their cells of origin and are a reservoir of renal information accessible in urine. When biopsy is not an option, EV present themselves as sentinels of function and damage, providing a non-invasive approach. However, the analysis of EV in urine requires prior isolation, which slows down and hinders transition into clinical practice. The aim of this study is to show the applicability of the “single particle interferometric reflectance imaging sensor” (SP-IRIS) technology through the ExoView® platform for the direct analysis of urine EV and proteins involved in renal function.
The ExoView® technology enables the quantification and phenotyping of EV present in urine and the quantification of their membrane and internal proteins. We have applied this technology to the quantification of urinary EV and their proteins with renal tubular expression, amnionless (AMN) and secreted frizzled-related protein 1 (SFRP1), using only 5 μl of urine. Tubular expression was confirmed by immunohistochemistry.
The mean size of the EV analysed was 59 ± 16 nm for those captured by tetraspanin CD63, 61 ± 16 nm for those captured by tetraspanin CD81, and 59 ± 10 for tetraspanin CD9, with CD63 being the majority EV subpopulation in urine (48.92%). The distribution of AMN and SFRP1 in the three capture tetraspanins turned out to be similar for both proteins, being expressed mainly in CD63 (48.23% for AMN and 52.1% for SFRP1).
This work demonstrates the applicability and advantages of the ExoView® technique for the direct analysis of urine EV and their protein content in relation to the renal tubule. The use of minimum volumes, 5 μl, and the total analysis time not exceeding three hours facilitate the transition of EV into daily clinical practice as sources of diagnostic information.
Las vesículas extracelulares (VEs) reflejan el estado fisiopatológico de sus células de origen y constituyen un reservorio de información renal accesible en orina. Cuando la biopsia no es una opción, las VEs se presentan como un centinela de funcionalidad y daño, constituyendo una aproximación no invasiva. Sin embargo, el análisis de las VEs de la orina requiere de un aislamiento previo que ralentiza y dificulta su traslación a la práctica clínica. El objetivo de este trabajo es mostrar la aplicabilidad de la tecnología “sensor de imágenes de reflectancia interferométrica de una sola partícula” (SP-IRIS) mediante la plataforma ExoView® para el análisis directo de las VEs de la orina y de proteínas implicadas en funcionalidad renal.
La tecnología ExoView® permite la cuantificación y fenotipado de las VEs presentes en orina y la cuantificación de sus proteínas, de membrana e internas. En este trabajo se aplica esta tecnología a la cuantificación de las VEs de la orina y de sus proteínas con expresión renal tubular, amnionless (AMN) y secreted frizzled-related protein 1 (SFRP1), empleando únicamente 5 μL de orina. La expresión tubular se confirmó por inmunohistoquímica.
. El tamaño medio de las VEs analizadas fue de 59 ± 16 nm para las capturadas por la tetraspanina CD63, 61 ± 16 nm para las capturadas por la tetraspanina CD81 y 59 ± 10 para la tetraspanina CD9, siendo CD63 la subpoblación de VEs mayoritaria en orina (48,92%). La distribución de AMN y SFRP1 en las 3 tetraspaninas de captura resultó ser similar para ambas proteínas, expresándose y mayoritariamente en CD63 (48,23% para AMN y 52,1% para SFRP1).
. Este trabajo evidencia la aplicabilidad y ventajas de la técnica ExoView® para el análisis directo de las VEs de la orina y su cargo proteico en relación con el túbulo renal. El empleo de volúmenes mínimos, 5 μL, y el tiempo total de análisis no superior a 3 horas facilita la traslación a la práctica clínica diaria de las VEs como fuentes de información diagnóstica.</description><identifier>ISSN: 2013-2514</identifier><identifier>EISSN: 2013-2514</identifier><identifier>DOI: 10.1016/j.nefroe.2023.05.020</identifier><identifier>PMID: 39054239</identifier><language>eng</language><publisher>Spain: Elsevier España, S.L.U</publisher><subject>Chronic kidney disease ; Enfermedad renal crónica ; ExoView ; Extracellular vesicles ; Leprechaun ; Nefropatía ; Nephropathy ; Orina tetraspaninas ; Urine tetraspanins ; Vesículas extracelulares</subject><ispartof>Nefrología, 2024-07, Vol.44 (4), p.503-508</ispartof><rights>2023 Sociedad Española de Nefrología</rights><rights>Copyright © 2023 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2020-979fb4c610db2f3eef64e68812657bff0f2fc66447a0443b338c1771f03ca2a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2013251424001470$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27901,27902,45756</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39054239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anfaiha-Sanchez, Miriam</creatorcontrib><creatorcontrib>Lago-Baameiro, Nerea</creatorcontrib><creatorcontrib>Santiago-Hernandez, Aranzazu</creatorcontrib><creatorcontrib>Martin-Blazquez, Ariadna</creatorcontrib><creatorcontrib>Pardo, María</creatorcontrib><creatorcontrib>Marta, Martin-Lorenzo</creatorcontrib><creatorcontrib>Alvarez-Llamas, Gloria</creatorcontrib><title>Urine beyond electrolytes: diagnosis through extracellular vesicles</title><title>Nefrología</title><addtitle>Nefrologia (Engl Ed)</addtitle><description>Extracellular vesicles (EV) reflect the pathophysiological state of their cells of origin and are a reservoir of renal information accessible in urine. When biopsy is not an option, EV present themselves as sentinels of function and damage, providing a non-invasive approach. However, the analysis of EV in urine requires prior isolation, which slows down and hinders transition into clinical practice. The aim of this study is to show the applicability of the “single particle interferometric reflectance imaging sensor” (SP-IRIS) technology through the ExoView® platform for the direct analysis of urine EV and proteins involved in renal function.
The ExoView® technology enables the quantification and phenotyping of EV present in urine and the quantification of their membrane and internal proteins. We have applied this technology to the quantification of urinary EV and their proteins with renal tubular expression, amnionless (AMN) and secreted frizzled-related protein 1 (SFRP1), using only 5 μl of urine. Tubular expression was confirmed by immunohistochemistry.
The mean size of the EV analysed was 59 ± 16 nm for those captured by tetraspanin CD63, 61 ± 16 nm for those captured by tetraspanin CD81, and 59 ± 10 for tetraspanin CD9, with CD63 being the majority EV subpopulation in urine (48.92%). The distribution of AMN and SFRP1 in the three capture tetraspanins turned out to be similar for both proteins, being expressed mainly in CD63 (48.23% for AMN and 52.1% for SFRP1).
This work demonstrates the applicability and advantages of the ExoView® technique for the direct analysis of urine EV and their protein content in relation to the renal tubule. The use of minimum volumes, 5 μl, and the total analysis time not exceeding three hours facilitate the transition of EV into daily clinical practice as sources of diagnostic information.
Las vesículas extracelulares (VEs) reflejan el estado fisiopatológico de sus células de origen y constituyen un reservorio de información renal accesible en orina. Cuando la biopsia no es una opción, las VEs se presentan como un centinela de funcionalidad y daño, constituyendo una aproximación no invasiva. Sin embargo, el análisis de las VEs de la orina requiere de un aislamiento previo que ralentiza y dificulta su traslación a la práctica clínica. El objetivo de este trabajo es mostrar la aplicabilidad de la tecnología “sensor de imágenes de reflectancia interferométrica de una sola partícula” (SP-IRIS) mediante la plataforma ExoView® para el análisis directo de las VEs de la orina y de proteínas implicadas en funcionalidad renal.
La tecnología ExoView® permite la cuantificación y fenotipado de las VEs presentes en orina y la cuantificación de sus proteínas, de membrana e internas. En este trabajo se aplica esta tecnología a la cuantificación de las VEs de la orina y de sus proteínas con expresión renal tubular, amnionless (AMN) y secreted frizzled-related protein 1 (SFRP1), empleando únicamente 5 μL de orina. La expresión tubular se confirmó por inmunohistoquímica.
. El tamaño medio de las VEs analizadas fue de 59 ± 16 nm para las capturadas por la tetraspanina CD63, 61 ± 16 nm para las capturadas por la tetraspanina CD81 y 59 ± 10 para la tetraspanina CD9, siendo CD63 la subpoblación de VEs mayoritaria en orina (48,92%). La distribución de AMN y SFRP1 en las 3 tetraspaninas de captura resultó ser similar para ambas proteínas, expresándose y mayoritariamente en CD63 (48,23% para AMN y 52,1% para SFRP1).
. Este trabajo evidencia la aplicabilidad y ventajas de la técnica ExoView® para el análisis directo de las VEs de la orina y su cargo proteico en relación con el túbulo renal. El empleo de volúmenes mínimos, 5 μL, y el tiempo total de análisis no superior a 3 horas facilita la traslación a la práctica clínica diaria de las VEs como fuentes de información diagnóstica.</description><subject>Chronic kidney disease</subject><subject>Enfermedad renal crónica</subject><subject>ExoView</subject><subject>Extracellular vesicles</subject><subject>Leprechaun</subject><subject>Nefropatía</subject><subject>Nephropathy</subject><subject>Orina tetraspaninas</subject><subject>Urine tetraspanins</subject><subject>Vesículas extracelulares</subject><issn>2013-2514</issn><issn>2013-2514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0E4lH4BwjlyKVh_YjdcEBCFS-pEhd6thxnXVylcbETRP89qVoQJ067h5md2Y-QSwo5BSpvlnmLLgbMGTCeQ5EDgwNyyoDyMSuoOPyzn5CzlJYAsmClOiYnvIRCMF6ekuk8-hazCjehrTNs0HYxNJsO021We7NoQ_Ip695j6BfvGX510Vhsmr4xMfvE5G2D6ZwcOdMkvNjPEZk_PrxNn8ez16eX6f1sbIeKMC5V6SphJYW6Yo4jOilQTiaUyUJVzoFjzkophDIgBK84n1iqFHXArWGG8hG53t1dx_DRY-r0yqdtG9Ni6JPmMBFKCQVykIqd1MaQUkSn19GvTNxoCnqLTy_1Dp_e4tNQ6KHiYLvaJ_TVCutf0w-vQXC3E-Dw56fHqJP12FqsfRzQ6Tr4_xO-ARPkgsg</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Anfaiha-Sanchez, Miriam</creator><creator>Lago-Baameiro, Nerea</creator><creator>Santiago-Hernandez, Aranzazu</creator><creator>Martin-Blazquez, Ariadna</creator><creator>Pardo, María</creator><creator>Marta, Martin-Lorenzo</creator><creator>Alvarez-Llamas, Gloria</creator><general>Elsevier España, S.L.U</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240701</creationdate><title>Urine beyond electrolytes: diagnosis through extracellular vesicles</title><author>Anfaiha-Sanchez, Miriam ; Lago-Baameiro, Nerea ; Santiago-Hernandez, Aranzazu ; Martin-Blazquez, Ariadna ; Pardo, María ; Marta, Martin-Lorenzo ; Alvarez-Llamas, Gloria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2020-979fb4c610db2f3eef64e68812657bff0f2fc66447a0443b338c1771f03ca2a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Chronic kidney disease</topic><topic>Enfermedad renal crónica</topic><topic>ExoView</topic><topic>Extracellular vesicles</topic><topic>Leprechaun</topic><topic>Nefropatía</topic><topic>Nephropathy</topic><topic>Orina tetraspaninas</topic><topic>Urine tetraspanins</topic><topic>Vesículas extracelulares</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anfaiha-Sanchez, Miriam</creatorcontrib><creatorcontrib>Lago-Baameiro, Nerea</creatorcontrib><creatorcontrib>Santiago-Hernandez, Aranzazu</creatorcontrib><creatorcontrib>Martin-Blazquez, Ariadna</creatorcontrib><creatorcontrib>Pardo, María</creatorcontrib><creatorcontrib>Marta, Martin-Lorenzo</creatorcontrib><creatorcontrib>Alvarez-Llamas, Gloria</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nefrología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anfaiha-Sanchez, Miriam</au><au>Lago-Baameiro, Nerea</au><au>Santiago-Hernandez, Aranzazu</au><au>Martin-Blazquez, Ariadna</au><au>Pardo, María</au><au>Marta, Martin-Lorenzo</au><au>Alvarez-Llamas, Gloria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urine beyond electrolytes: diagnosis through extracellular vesicles</atitle><jtitle>Nefrología</jtitle><addtitle>Nefrologia (Engl Ed)</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>44</volume><issue>4</issue><spage>503</spage><epage>508</epage><pages>503-508</pages><issn>2013-2514</issn><eissn>2013-2514</eissn><abstract>Extracellular vesicles (EV) reflect the pathophysiological state of their cells of origin and are a reservoir of renal information accessible in urine. When biopsy is not an option, EV present themselves as sentinels of function and damage, providing a non-invasive approach. However, the analysis of EV in urine requires prior isolation, which slows down and hinders transition into clinical practice. The aim of this study is to show the applicability of the “single particle interferometric reflectance imaging sensor” (SP-IRIS) technology through the ExoView® platform for the direct analysis of urine EV and proteins involved in renal function.
The ExoView® technology enables the quantification and phenotyping of EV present in urine and the quantification of their membrane and internal proteins. We have applied this technology to the quantification of urinary EV and their proteins with renal tubular expression, amnionless (AMN) and secreted frizzled-related protein 1 (SFRP1), using only 5 μl of urine. Tubular expression was confirmed by immunohistochemistry.
The mean size of the EV analysed was 59 ± 16 nm for those captured by tetraspanin CD63, 61 ± 16 nm for those captured by tetraspanin CD81, and 59 ± 10 for tetraspanin CD9, with CD63 being the majority EV subpopulation in urine (48.92%). The distribution of AMN and SFRP1 in the three capture tetraspanins turned out to be similar for both proteins, being expressed mainly in CD63 (48.23% for AMN and 52.1% for SFRP1).
This work demonstrates the applicability and advantages of the ExoView® technique for the direct analysis of urine EV and their protein content in relation to the renal tubule. The use of minimum volumes, 5 μl, and the total analysis time not exceeding three hours facilitate the transition of EV into daily clinical practice as sources of diagnostic information.
Las vesículas extracelulares (VEs) reflejan el estado fisiopatológico de sus células de origen y constituyen un reservorio de información renal accesible en orina. Cuando la biopsia no es una opción, las VEs se presentan como un centinela de funcionalidad y daño, constituyendo una aproximación no invasiva. Sin embargo, el análisis de las VEs de la orina requiere de un aislamiento previo que ralentiza y dificulta su traslación a la práctica clínica. El objetivo de este trabajo es mostrar la aplicabilidad de la tecnología “sensor de imágenes de reflectancia interferométrica de una sola partícula” (SP-IRIS) mediante la plataforma ExoView® para el análisis directo de las VEs de la orina y de proteínas implicadas en funcionalidad renal.
La tecnología ExoView® permite la cuantificación y fenotipado de las VEs presentes en orina y la cuantificación de sus proteínas, de membrana e internas. En este trabajo se aplica esta tecnología a la cuantificación de las VEs de la orina y de sus proteínas con expresión renal tubular, amnionless (AMN) y secreted frizzled-related protein 1 (SFRP1), empleando únicamente 5 μL de orina. La expresión tubular se confirmó por inmunohistoquímica.
. El tamaño medio de las VEs analizadas fue de 59 ± 16 nm para las capturadas por la tetraspanina CD63, 61 ± 16 nm para las capturadas por la tetraspanina CD81 y 59 ± 10 para la tetraspanina CD9, siendo CD63 la subpoblación de VEs mayoritaria en orina (48,92%). La distribución de AMN y SFRP1 en las 3 tetraspaninas de captura resultó ser similar para ambas proteínas, expresándose y mayoritariamente en CD63 (48,23% para AMN y 52,1% para SFRP1).
. Este trabajo evidencia la aplicabilidad y ventajas de la técnica ExoView® para el análisis directo de las VEs de la orina y su cargo proteico en relación con el túbulo renal. El empleo de volúmenes mínimos, 5 μL, y el tiempo total de análisis no superior a 3 horas facilita la traslación a la práctica clínica diaria de las VEs como fuentes de información diagnóstica.</abstract><cop>Spain</cop><pub>Elsevier España, S.L.U</pub><pmid>39054239</pmid><doi>10.1016/j.nefroe.2023.05.020</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2013-2514 |
ispartof | Nefrología, 2024-07, Vol.44 (4), p.503-508 |
issn | 2013-2514 2013-2514 |
language | eng |
recordid | cdi_proquest_miscellaneous_3084774706 |
source | ScienceDirect |
subjects | Chronic kidney disease Enfermedad renal crónica ExoView Extracellular vesicles Leprechaun Nefropatía Nephropathy Orina tetraspaninas Urine tetraspanins Vesículas extracelulares |
title | Urine beyond electrolytes: diagnosis through extracellular vesicles |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T22%3A37%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urine%20beyond%20electrolytes:%20diagnosis%20through%20extracellular%20vesicles&rft.jtitle=Nefrolog%C3%ADa&rft.au=Anfaiha-Sanchez,%20Miriam&rft.date=2024-07-01&rft.volume=44&rft.issue=4&rft.spage=503&rft.epage=508&rft.pages=503-508&rft.issn=2013-2514&rft.eissn=2013-2514&rft_id=info:doi/10.1016/j.nefroe.2023.05.020&rft_dat=%3Cproquest_cross%3E3084774706%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2020-979fb4c610db2f3eef64e68812657bff0f2fc66447a0443b338c1771f03ca2a13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3084774706&rft_id=info:pmid/39054239&rfr_iscdi=true |